Hikma

For over 45 years, Hikma has been dedicated to putting better health within reach for millions of people around the world. By producing high-quality, affordable medicines, Hikma plays a critical role in supporting healthcare systems and improving patient outcomes on a global scale.

Headquartered in the United Kingdom, Hikma operates as a global pharmaceutical leader with a strong local presence across the United States, the Middle East and North Africa (MENA), and Europe. This regional insight allows the company to respond effectively to diverse healthcare needs while transforming scientific innovation into accessible, life-enhancing solutions.

Hikma offers a broad portfolio of branded and non-branded generic medicines, addressing a wide range of therapeutic areas. Through a balance of creativity and practicality, the company delivers solutions that meet the real-world challenges faced by healthcare providers and their patients. This commitment to accessibility, quality, and affordability is what sets Hikma apart in an increasingly complex healthcare landscape.

With a team of approximately 9,500 colleagues, Hikma is deeply committed to enriching communities and advancing global health. Its people are the driving force behind the company’s mission, helping to shape a healthier world with each medicine produced and delivered.

In addition to its core pharmaceutical business, Hikma is a leading licensing partner, collaborating with other healthcare innovators to expand its reach and bring more therapies to more people. Through its venture capital arm, Hikma also invests in emerging health technologies, helping bring breakthrough innovations to market and accelerating the future of healthcare.

As a company built on trust, quality, and impact, Hikma continues to play a vital role in improving lives—delivering dependable medicines, fostering innovation, and ensuring that better health is always within reach.